bpc 157 safety fda approval status warning bpc-157 not approved A closer look at the unapproved peptide injections Survey: Half of Peptide-Users Aren't
Description
BPC 157 as potential agent in treating osteoarthritis: a preliminary study

the dysfunction was reversible when vitamin C was discontinued

however, the trial was powered to only detect much larger reductions

The version of B12 that our body does BEST with includes those versions which are pre-activated, pre-methylated, and ready for utilization by the body
